Sunday, Sep 25, 2022
×
Outlook.com
×

Aurobindo Pharma

Aurobindo Pharma Profit Falls 28% To Rs 576 Crore In March Quarter

The company had posted a consolidated net profit of Rs 801.18 crore in the same period of the preceding fiscal, Aurobindo Pharma said in a regulatory filing.

31 May 2022

It reported a consolidated net profit of Rs 777.3 crore in the same period of the previous fiscal.

Aurobindo Pharma Net Profit Drops 22% To Rs 604 Crore In December Quarter

Revenue from operations declined by 1 per cent to Rs 6,002.2 crore as against Rs 6,064.8 crore in the same period of last financial year.


Aurobindo Pharma’s Covid-19 Drug Molnupiravir Launches In India

Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.


Aurobindo, Sun Pharma Recall Products In US Market

While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes.

24 April 2022

Here Is Why Aurobindo Pharma Shares Fell Over 4.5% Today

The action follows the recent inspection of the facility by the USFDA in August 2021, the drugmaker said in a stock exchange filing.


Pre-Market Report: Britannia, Aurobindo Pharma Results Quarterly Results, Paytm IPO To Watch Out For

Markets were closed for the Diwali vacation since Thursday. How investors react on Monday would depend on what they see as a priority.

08 November 2021

Lupin Gets USFDA Nod For Generic Product

The Mumbai-based company's product is the generic version of Viatris Specialty LLC's Revatio

24 March 2022

Advertisement

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement